HRT Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

HRT Financial’s Portfolio CLVS Stock Details CLVS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$235K	Sell
2022 Q1	$2.21M	Buy
2021 Q4	$478K	Buy
2021 Q2	–	Sell
2021 Q1	$852K	Buy